Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)

OBJECTIVE: The practices pertaining to hereditary breast and ovarian cancer (HBOC) in Japan have been rapidly changing owing to the clinical development of poly(ADP-ribose) polymerase inhibitors, the increasing availability of companion diagnostics, and the broadened insurance coverage of HBOC manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Yusuke, Masuda, Kenta, Hiraswa, Akira, Takehara, Kazuhiro, Tsuda, Hitoshi, Watanabe, Yoh, Oda, Katsutoshi, Nagase, Satoru, Mandai, Masaki, Okamoto, Aikou, Yaegashi, Nobuo, Mikami, Mikio, Enomoto, Takayuki, Aoki, Daisuke, Katabuchi, Hidetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428299/
https://www.ncbi.nlm.nih.gov/pubmed/35882604
http://dx.doi.org/10.3802/jgo.2022.33.e61

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428299/
https://www.ncbi.nlm.nih.gov/pubmed/35882604
http://dx.doi.org/10.3802/jgo.2022.33.e61

Ejemplares similares